A Phase IIa Interferon Free Combination Hepatitis C Trial of Simeprevir (TMC435) and TMC647055 Will Commence Shortly
-
2
pages
-
English
-
Documents
Publié par
medivir
-
2
pages
-
English
-
Documents
Description
A Phase IIa Interferon Free Combination Hepatitis C Trial of Simeprevir (TMC435) and TMC647055 Will Commence Shortly PR Newswire STOCKHOLM, September 20, 2012 STOCKHOLM, September 20, 2012 /PRNewswire/ -- Medivir AB (OMX: MVIR), announced today that simeprevir (TMC435) and TMC647055, a non-nucleoside inhibitor (NNI) will enter a phase IIa interferon
-
Publié par
-
Langue
English
Ajouté à mes notifications
Vous serez informé des prochaines publications.